Regulatory Initiative: Prescription Status of Drugs (Repeal of Schedule F) - Forward Regulatory Plan 2012-2014

Title or working title of the regulatory initiative: Prescription Status of Drugs (Repeal of Schedule F)

Description of the objective:
Regulations are needed to bring into force changes to the Food and Drugs Act (FDA) that were established under the Jobs, Growth and Long-Term Prosperity Act. A regulatory proposal will be developed to replace the current process by repealing schedule F and replacing it with an administrative prescription drug list.

Enabling Act:
Food and Drugs Act
Jobs, Growth and Long-term Prosperity Act

Indication of business impacts:
There may be business impacts.  The "One-for-One" Rule and/or the Small Business Lens may apply.

Public consultation opportunities:

Canadians have the opportunity to provide input during the  Canada Gazette, Part I public comment period, currently open until March 7, 2013.

To support the proposed regulatory amendment, a draft guidance document and draft of the new Prescription Drug List have also been developed.

Information on previous consultations and details on upcoming opportunities for consultation will be provided on the Health Canada Website for Regulatory Modernization.

Departmental contact:

David K. Lee
Director
Office of Legislative and Regulatory Modernization
Policy, Planning and International Affairs Directorate
Health Products and Food Branch
Health Canada

Telephone number: 613-946-6586

Email address: LRM-MLR@hc-sc.gc.ca

For More Information

•  Government-Wide Forward Regulatory Plans
• The  Cabinet Directive on Regulatory Management
• The  Red Tape Reduction Action Plan
• The  Canada-United States Regulatory Cooperation Council

To learn about upcoming or ongoing consultations on proposed federal regulations, visit the  Canada Gazette and  Consulting with Canadians websites.